Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Harry Hamburg / AP

Scott Gottlieb, President Trump's nominee to run the Food and Drug Administration, is coming to the Hill this morning for his confirmation hearing. Here's a guide to what you might hear when he goes before the Senate HELP Committee:

  • 21st Century Cures: HELP Committee Chairman Lamar Alexander will press Gottlieb on his plans for implementing the legislation Congress passed last year. In his opening statement, Alexander will say that the key is "a regulatory process that is efficient and effective enough to bring safe discoveries to patients in a timely way."
  • Generic drug backlog: Gottlieb could be asked what he'd do to clear the backlog of unapproved generic drugs. Republicans like that as a way to help bring down drug prices through more competition.
  • FDA user fee agreements: Those have to be reauthorized by the end of September, and Alexander wants to get the work done before the August recess. Gottlieb could be asked for his views.
  • Industry ties: Gottlieb is well liked by health care wonks in both parties, but the biggest sticking point for Democrats is his years of financial ties to pharmaceutical companies. Ranking member Patty Murray and other Democrats are likely to ask how he'd address potential conflicts of interest.
  • Drug reimportation: Don't be surprised if Gottlieb gets a question about it. Simple reason: Trump likes it, Gottlieb hates it.
  • Anti-vaxxers: Same reason: Trump likes them, Gottlieb doesn't.

Go deeper

Dan Primack, author of Pro Rata
23 mins ago - Economy & Business

Scoop: Red Sox strike out on deal to go public

Illustration: Sarah Grillo/Axios

The parent company of the Boston Red Sox and Liverpool F.C. has ended talks to sell a minority ownership stake to RedBall Acquisition, a SPAC formed by longtime baseball executive Billy Beane and investor Gerry Cardinale, Axios has learned from multiple sources. An alternative investment, structured more like private equity, remains possible.

Why it matters: Red Sox fans won't be able to buy stock in the team any time soon.

Trump political team disavows "Patriot Party" groups

Marine One carries President Trump away from the White House on Inauguration Day. Photo: Patrick Smith/Getty Images

Donald Trump's still-active presidential campaign committee officially disavowed political groups affiliated with the nascent "Patriot Party" on Monday.

Why it matters: Trump briefly floated the possibility of creating a new political party to compete with the GOP — with him at the helm. But others have formed their own "Patriot Party" entities during the past week, and Trump's team wants to make clear it has nothing to do with them.